How does ALX's PE Ratio compare to its peers?

ALX is good value based on its Price-To-Earnings Ratio (23x) compared to the peer average (46.6x).

How does ALX's PE Ratio compare vs other companies in the Global Infrastructure Industry?

ALX is expensive based on its Price-To-Earnings Ratio (23x) compared to the Global Infrastructure industry average (14.2x).

What is ALX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ALX is expensive based on its Price-To-Earnings Ratio (23x) compared to the estimated Fair Price-To-Earnings Ratio (23x).

What is the Fair Price of ALX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

ALX (A$4.72) is trading below our estimate of [[fair value]] (A$9.32)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Target price is less than 20% higher than the current share price.

Atlas Arteria (CHIA:ALX) - Stock Price, News & Analysis

ALX Stock Overview

Owns, develops, and operates toll roads. More details

ALX fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	4/6
Past Performance	2/6
Financial Health	3/6
Dividends	4/6

Rewards

Trading at 49.4% below our estimate of its fair value

Earnings are forecast to grow 21.84% per year

Risk Analysis

Dividend of 8.4% is not well covered by earnings or free cash flows

Atlas Arteria Limited Competitors

Transurban Group

ASX:TCL

AU$39.0b

Qube Holdings

ASX:QUB

AU$6.9b

Aurizon Holdings

ASX:AZJ

AU$6.1b

Dalrymple Bay Infrastructure

ASX:DBI

AU$1.7b

Price History & Performance

Summary of all time highs, changes and price drops for Atlas Arteria
Historical stock prices
Current Share Price	AU$4.72
52 Week High	AU$6.34
52 Week Low	AU$4.63
Beta	0.76
11 Month Change	-5.13%
3 Month Change	-7.09%
1 Year Change	-18.06%
33 Year Change	-30.94%
5 Year Change	-38.58%
Change since IPO	50.80%

Recent updates

Shareholder Returns

	ALX	AU Infrastructure	AU Market
7D	-1.0%	0.6%	0.9%
1Y	-18.1%	-0.7%	17.7%

Return vs Industry: ALX underperformed the Australian Infrastructure industry which returned -0.7% over the past year.

Return vs Market: ALX underperformed the Australian Market which returned 17.2% over the past year.

Price Volatility

Is ALX's price volatile compared to industry and market?
ALX volatility
ALX Average Weekly Movement	3.4%
Infrastructure Industry Average Movement	2.5%
Market Average Movement	8.5%
10% most volatile stocks in AU Market	17.2%
10% least volatile stocks in AU Market	3.3%

Stable Share Price: ALX has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: ALX's weekly volatility (3%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2009	n/a	Hugh Wehby	www.atlasarteria.com

Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 31.14% of interest in the APRR and A79 and 31.17% interest in the ADELAC located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago and 100% interest in the Dulles Greenway located in Virginia, United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018.

Atlas Arteria Limited Fundamentals Summary

How do Atlas Arteria's earnings and revenue compare to its market cap?
ALX fundamental statistics
Market cap	AU$6.91b
Earnings (TTM)	AU$300.20m
Revenue (TTM)	AU$140.10m

23.0x

P/E Ratio

49.3x

P/S Ratio

Is ALX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALX income statement (TTM)
Revenue	AU$140.10m
Cost of Revenue	AU$47.80m
Gross Profit	AU$92.30m
Other Expenses	-AU$207.90m
Earnings	AU$300.20m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Feb 26, 2025

Earnings per share (EPS)	0.21
Gross Margin	65.88%
Net Profit Margin	214.28%
Debt/Equity Ratio	27.2%

How did ALX perform over the long term?

See historical performance and comparison

Dividends

8.4%

Current Dividend Yield

194%

Payout Ratio

ALX Stock Overview

Rewards

Risk Analysis

Atlas Arteria Limited Competitors

ASX:TCL

AU$39.0b

ASX:QUB

AU$6.9b

ASX:AZJ

AU$6.1b

ASX:DBI

AU$1.7b

Price History & Performance

Recent News & Updates

First half dividend of AU$0.20 announced

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024

High number of new directors

First half 2024 earnings released: EPS: AU$0.099 (vs AU$0.12 in 1H 2023)

Atlas Arteria Limited Appoints Hugh Wehby as Managing Director

Atlas Arteria Limited to Report First Half, 2025 Results on Aug 28, 2025

Recent updates

First half dividend of AU$0.20 announced

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024

High number of new directors

First half 2024 earnings released: EPS: AU$0.099 (vs AU$0.12 in 1H 2023)

Atlas Arteria Limited Appoints Hugh Wehby as Managing Director

Atlas Arteria Limited to Report First Half, 2025 Results on Aug 28, 2025

Final dividend of AU$0.20 announced

Atlas Arteria Limited Announces the Retirement of Graeme Bevans as CEO and Managing Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024

Atlas Arteria Limited, Annual General Meeting, May 15, 2024

Atlas Arteria Limited, Annual General Meeting, May 16, 2024

Full year 2023 earnings released: EPS: AU$0.22 (vs AU$0.25 in FY 2022)

Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Payable on 5 October 2023

First half 2023 earnings released: EPS: AU$0.12 (vs AU$0.13 in 1H 2022)

Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023

Atlas Arteria Limited to Report First Half, 2024 Results on Aug 29, 2024

Atlas Arteria Limited Appoints Ken Daley as Director

Atlas Arteria Limited Announces Caroline Foulger Will Retire as A Director, with Effect from 1 July 2023

Full year 2022 earnings released: EPS: AU$0.25 (vs AU$0.19 in FY 2021)

Insufficient new directors

Atlas Arteria Limited Announces Board Changes

Atlas Arteria Limited (ASX:ALX) completed the acquisition of 66.67% stake in Skyway Concession Company, LLC from CPP Investments and OMERS Infrastructure.

Now 20% undervalued after recent price drop

Atlas Arteria Limited, Annual General Meeting, Apr 27, 2023

Atlas Arteria Limited to Report Q4, 2022 Results on Feb 23, 2023

Investor sentiment deteriorated over the past week

Atlas Arteria Limited Provides Distribution Guidance for the Year 2023

Atlas Arteria Limited (ASX:ALX) entered into an agreement to acquire a 66.67% stake in Skyway Concession Company, LLC for $2 billion.

First half 2022 earnings released: EPS: AU$0 (vs AU$0.074 in 1H 2021)

Atlas Arteria Limited Provides Dividend Guidance for the First Half of 2022

Investor sentiment improved over the past week

Atlas Arteria Limited Announces Executive Changes

Independent Non-Executive Director recently bought AU$76k worth of stock

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Insider recently bought AU$67k worth of stock

First half 2021 earnings released: EPS AU$0.074 (vs AU$0.14 loss in 1H 2020)

Independent Chairman of the Board recently bought AU$100k worth of stock

Full year 2020 earnings released: AU$0.061 loss per share (vs AU$0.024 profit in FY 2019)

Revenue misses expectations

Atlas Arteria Limited Announces Board Changes

New 90-day low: AU$6.00

Atlas Arteria Limited to Report Fiscal Year 2020 Results on Feb 25, 2021

Atlas Arteria Limited, Annual General Meeting, Apr 27, 2021

Atlas Arteria Limited Announces Changes to its Board

New 90-day low: AU$5.95

New 90-day low: AU$6.10

New 90-day low - AU$6.11

Atlas Arteria Limited (ASX:ALX) acquired 6.14% stake in APRR and ADALEC from Macquarie European Infrastructure Fund II managed by Macquarie Infrastructure and Real Assets (Europe) Limited.

Earnings released

Atlas Arteria Limited has completed a Follow-on Equity Offering in the amount of AUD 74.999999 million.